In vivo immunosuppressive effect of purine nucleoside phosphorylase inhibitor-8-amino-9-benzyl-guanine in canine renal allograft rejection.
Lin
C Y
CY
Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
Yen
C Y
CY
D000818:Animals; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000949:Histocompatibility Antigens Class II / Q000032:analysis / Q000096:biosynthesis; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D011683:Purine-Nucleoside Phosphorylase / Q000037:antagonists & inhibitors*; D014184:Transplantation, Homologous
D000949:Histocompatibility Antigens Class II; D007166:Immunosuppressive Agents; C047715:8-amino-9-benzylguanine; D006147:Guanine; D011683:Purine-Nucleoside Phosphorylase